Second dose of MMR vaccine: health professionals' level of confidence in the vaccine and attitudes towards the second dose.
Public concerns have been raised about the safety of MMR vaccine following the publication of two studies linking the vaccine to inflammatory bowel disease and to a syndrome of Ileal-lymphoid-nodular hyperplasia, non-specific colitis and pervasive developmental disorder. Our study had two aims, to determine whether health professionals' confidence in MMR vaccine was affected and to assess professional knowledge and attitudes towards the second dose of MMR. In July 1998 we undertook a questionnaire survey of general practitioners, practice nurses and health visitors in an inner city area. A significant fall was found in professional confidence following the two publications and the subsequent media coverage (from 59.4% to 40.9%). Forty percent of respondents were unsure about the need for a second dose of MMR vaccine and more than one in ten professionals stated that it was not necessary. It is reasonable to assume that this reduced confidence in the safety of MMR and the professional uncertainty about the second dose have contributed to the observed decline in MMR uptake rates. More professional and public education appears to be needed.
Accident and Emergency Department, Bolton General Hospital.
A
A
Smith
R
R
McCann
I
I
McKinlay
D001291:Attitude of Health Personnel; D007722:Health Knowledge, Attitudes, Practice; D006302:Health Services Research; D006801:Humans; D007117:Immunization, Secondary / Q000592:standards*; D022542:Measles-Mumps-Rubella Vaccine / Q000008:administration & dosage* / Q000009:adverse effects; D009726:Nurses / Q000523:psychology*; D010820:Physicians / Q000523:psychology*; D012449:Safety; D013222:State Medicine; D006113:United Kingdom
D022542:Measles-Mumps-Rubella Vaccine